Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Muscarinic acetylcholine receptor M3 | ||
Ligand | BDBM50522829 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1888526 (CHEMBL4390203) | ||
Ki | 0.650000±n/a nM | ||
Citation | Yamashita, Y; Tanaka, KI; Yamakawa, N; Asano, T; Kanda, Y; Takafuji, A; Kawahara, M; Takenaga, M; Fukunishi, Y; Mizushima, T Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity. Bioorg Med Chem27:3339-3346 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Muscarinic acetylcholine receptor M3 | |||
Name: | Muscarinic acetylcholine receptor M3 | ||
Synonyms: | ACM3_HUMAN | CHRM3 | Cholinergic, muscarinic M3 | Muscarinic Receptors M3 | Muscarinic receptor M3 | RecName: Full=Muscarinic acetylcholine receptor M3 | ||
Type: | Enzyme | ||
Mol. Mass.: | 66151.03 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P20309 | ||
Residue: | 590 | ||
Sequence: |
| ||
BDBM50522829 | |||
n/a | |||
Name | BDBM50522829 | ||
Synonyms: | CHEMBL4457734 | ||
Type | Small organic molecule | ||
Emp. Form. | C29H32BrNO3S | ||
Mol. Mass. | 554.538 | ||
SMILES | [Br-].OC(C(=O)OC1C[N+]2(CCSc3ccccc3)CCC1CC2)(c1ccccc1)c1ccccc1 |(58.41,-19.71,;49.43,-20.93,;50.77,-21.71,;52.1,-22.47,;52.11,-24.01,;53.44,-21.7,;54.77,-22.46,;56.1,-21.69,;57.43,-22.46,;58.76,-21.7,;60.1,-22.47,;61.43,-21.7,;62.76,-22.48,;62.76,-24.02,;64.09,-24.79,;65.43,-24.02,;65.42,-22.47,;64.09,-21.71,;57.43,-24.01,;56.1,-24.77,;54.77,-24.01,;56.27,-23.8,;55.92,-22.75,;50.76,-20.17,;52.1,-19.39,;52.09,-17.86,;50.75,-17.09,;49.42,-17.87,;49.43,-19.41,;49.44,-22.48,;48.1,-21.71,;46.77,-22.48,;46.77,-24.02,;48.12,-24.79,;49.45,-24.01,)| | ||
Structure |